BioSpring Bio là một công ty dược phẩm sản xuất sữa công thức bên thứ ba đầu tiên ở Lào mở rộng thị trường toàn cầu Các mục tiêu phát triển dài hạn bao gồm phục vụ các thị trường Đông Nam Á, Nam Á, Ả Rập, Đông Âu, Trung Á, Tây…
貝泉生物是寮國第1家拓展全球市場的第三方配方製造製藥企業 長期發展目標包括服務東南亞、南亞、阿拉伯、東歐、中亞、西亞、非洲、拉丁美洲等市場 計劃中的產品線包括流行病藥物，抗腫瘤藥物，罕見病藥物，以及長期保健和伴侶動物藥物 2022年06月14日，寮國，永珍--貝泉生物（“BioSpring Group.LTD”“BioSpring”）宣布將公司定位為圍繞影響公眾健康的流行病，重大疾病（癌症），罕見病，以及長期保健和伴侶動物的提供完整解決方案的第三方配方製造綜合製藥企業。 此次發布發展戰略是寮國初創藥企貝泉生物首次進入公眾視野。貝泉生物將根據疾病分類、藥品組合、地理位置和藥品製程進行多元化；目標是在全球範圍內創建高效率的研究、製造、供應鍊和商業平台；不斷提高質量標準；以及培養其全球員工隊伍。 貝泉生物創始人兼首席執行官Samuel表示：“我們是寮國第一家宣布進入國際市場並服務全球客戶的製藥企業，我們會提供從API到成品藥物的配方製造服務，以及在目標市場提交成品藥物的註冊申報。” “我們期待幫助更多的人獲得有效，安全和負擔的起的通用藥物，以及創新的商業模式提升罕見病藥物的可及性。” 療愈無界（Healing Beyond Borders） “療愈無界”是貝泉生物未來十年發展戰略的核心表述,同時也是其品牌建設的起點。與其他仿製藥企業不同，貝泉生物將嘗試在危害公眾健康的流行病和罕見病孤兒藥領域投資，探索合理的商業模式，以提升藥物的可及性。同時計劃積極與學術界在轉化醫學領域合作，為重塑企業創新價值奠定基礎。 當下業務 貝泉生物正在開發通用版抗病毒藥物（Anit-HIV/AIDS），以滿足東南亞地區未滿足的醫療需求。同時尋找抗癌藥領域的製造產能收購，特別是標靶療法相關的資產，以組建從API到成品藥物的製造能力，快速進入這一增長中的市場。 关于貝泉生物 貝泉生物（“BioSpring Group.LTD”“BioSpring”）於2022年創建於寮國永珍賽色塔綜合開發區，是該國成長最快的通用藥物製造企業，並且是該國第一家面向國際市場的製藥企業，服務於亞洲、非洲、歐洲和拉丁美洲等多個國家和地區。訪問biospring.ltd了解更多信息。 前瞻性聲明 在適用的法律和法規範圍內，本新聞稿中出現的“計劃”、“目標”、“期待”、“預測”及其類似表述均屬於前瞻性聲明。此述的前瞻性聲明涉及一系列風險和不確定性，可能與實際結果存在重大差異。導致這種差異的重要因素包括但不限於：法規與/或經濟狀況的變動、臨床研究結果的不確定性、面臨的各種市場風險等超出公司可掌控範圍的因素。 貝泉生物媒體代理RxLibra 公共關係 (PR) 聯繫人:Spencer 電子郵件:info@rxlibra.com 訪問www.RxLibra.com 消息來源 BioSpring Group.LTD
BioSpring is the first third-party formula manufacturing pharmaceutical company in Laos to expand the global market Long-term development goals include serving Southeast Asia, South Asia, Arabia, Eastern Europe, Central Asia, West Asia, Africa, Latin America and other markets Planned product lines include epidemiological drugs, oncology drugs, rare disease drugs, and long-term…
Reprint News release (On Monday, May 23) EPA triggered its emerging viral pathogen (EVP) guidance in response to recent cases of Monkeypox in the United States. When rare or novel viruses cause outbreaks of disease, there may be few if any disinfectants that have been registered for use against that…
In view of the increasing reports of Monkeypox (MPX) cases in non-endemic countries, as part of a proactive and risk-based approach for management of Monkeypox and to ensure advance preparedness across the country, Union Ministry of Health and Family Welfare has issued ‘Guidelines on Management of Monkeypox Disease’. There are…
Reprint News release (STOCKHOLM, May 27) - The European Union is working on a common purchasing agreement for vaccines and antiviralsagainst monkeypox, as cases of the viral disease usually endemic to Africa gather steam in Europe and beyond. A broad consensus was reached in principle with member states for the…
Reprint News release (SEOUL, South Korea, May 25, 2022) Hyundai Bioscience will go straight to the US with its broad-spectrum antiviral drug candidate to treat monkeypox. Hyundai Bioscience has decided to submit a request for a fast track processing to the U.S. Food and Drug Administration (FDA) for CP-COV03, an oral antiviral medicine…
Reprint News release (May 25, 2022 03:00 AM Eastern Daylight Time) DAVOS, Switzerland--Pfizer Inc. (NYSE: PFE) today launched ‘An Accord for a Healthier World.’ This groundbreaking initiative aims to provide all of Pfizer’s patented, high-quality medicines and vaccines available in the U.S. or the European Union on a not-for-profit basis to 1.2…
Reprint News release （28 November 2017) WHO urges governments to take action An estimated 1 in 10 medical products circulating in low- and middle-income countries is either substandard or falsified, according to new research from WHO. This means that people are taking medicines that fail to treat or prevent disease. Not…
Vientiane,Laos PDR, May 21, 2022 /LienTeh/ Yesterday，Members of several leading pharmaceutical companies in Laos discussed the spread of monkeypox and reached a preliminary plan. Companies involved in the formulation of the plan include：RxLibra、SaiLin-Bio、BioSpring、DAXIONG Pharma...etc. The above companies initially selected Tecovirimat as the treatment drug for monkeypox, and started to study the production…
Unlocking Global Health Opportunities: Mitotane (MITODX)
How many generic versions of Epclusa (Sofosbuvir/Velpatasvir…
8 fármacos dirigidos para el tratamiento de la leucemia linf…
8 targeted drugs for treatment of the Chronic lymphocytic le…
4 fármacos dirigidos para el tratamiento del Carcinoma Endom…
Copyright © 2021-2022 LienTeh.net All rights reserved.
